Europe
Medtronic plc, the global leader in medical technology, announced that it has initiated the company’s pivotal trial for its next-generation Guardian continuous glucose monitoring sensor designed to improve accuracy and overall system performance, reduce sensor calibrations and enhance overall user experience.
Medtronic plc, the global leader in medical technology, announced the enrollment of the first study participants in the company’s pivotal trial of its Bluetooth® enabled MiniMed 780G advanced hybrid closed loop system.
“HealthCaring Conversations is a blueprint for having an efficient but empathic conversation with a patient,” said Suzann Johnson, Janssen’s associate director of clinical insights and experience. “We’re taking good conversations and making them great by putting the patient at the center of every conversation.”
The two companies will pair CStone’s CS1001 with Bayer’s regorafenib, an oral multi-kinase inhibitor that targets VEGFR, FGFR, CSF1R and other receptors.
Government agencies in the United States and U.K. are scrutinizing Roche’s planned acquisition of the gene therapy company.
A Phase III trial compared Sanofi’s Soliqua/Suliqua to other GLP-1 receptor agonists (GLP-1 RA), with Soliqua showing a superior decrease of average blood sugar level (HbA1c) after 26 weeks.
With the treatment center at the Paracelsus Clinic in Zwickau another geographically important location will soon offer NanoTherm therapy for brain tumor patients
CYROLITE® acrylic-based polymers have been a proven material in medical technology for over 40 years.
Polyphor AG presented yesterday new data from pulmonary delivery of its lead antibacterial candidate of the novel Outer Membrane Protein Targeting Antibiotic class, murepavadin, at the 42nd European Cystic Fibrosis Conference in Liverpool, United Kingdom.
Here’s a look at some of last week’s clinical trial announcements, including some from the American Society of Clinical Oncology Annual Meeting you might have missed.
PRESS RELEASES